| Literature DB >> 12052918 |
Lawrence Steinman1, Roland Martin, Claude Bernard, Paul Conlon, Jorge R Oksenberg.
Abstract
Recent technological breakthroughs allowing for large-scale analysis of gene transcripts and large-scale monitoring of the immune response with protein chips are revealing new participants in the pathogenesis of multiple sclerosis. Some of these participants may be useful targets for therapy.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12052918 DOI: 10.1146/annurev.neuro.25.112701.142913
Source DB: PubMed Journal: Annu Rev Neurosci ISSN: 0147-006X Impact factor: 12.449